A Biomarker Study in Men With Localized Prostate Cancer Treated With Aglatimagene Besadenovec
Abroad (travel likely)RecruitingPHASE2
Conditions
Prostate Cancer Patients Treated by Radiotherapy · Prostate Cancer (Adenocarcinoma)
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Academic Urology and Urogynecology of Arizona, Peoria, Arizona, United States
Contact: Principal Investigator (Chandan Kundavaram, M.D.)Colorado Clinical Research, Lakewood, Colorado, United States
Contact: Study coordinator (Stephanie Melgar-Donis) · Stephanie.melgar-donis@coloradouro.com · 720-213-3130Contact: Principal Investigator (Thomas Facelle, M.D.)Urology Associates, Littleton, Colorado, United States
Contact: Principal Investigator (James Fagelson, M.D.)Chesapeake Urology Research Associates, Towson, Maryland, United States
Contact: Principal Investigator (Ronald Tutrone, M.D.)Sheldon Freedman, MD Ltd., Las Vegas, Nevada, United States
Contact: Principal Investigator (Sheldon Freedman, M.D.)Summit Health, Saddle Brook, New Jersey, United States
Contact: Study coordinator (Michelle Mackenzie, RN OCN CCRC) · Mmackenzie@summithealth.com · 973-436-1755Contact: Principal Investigator (Glen Gejerman, M.D.)START Carolinas, Myrtle Beach, South Carolina, United States
Contact: Study coordinator (Taylor Stephenson) · taylor.stephenson@startresearch.com · (843) 839-1679Contact: Principal Investigator (John Sylvester, M.D.)